Lineage Cell Therapeutics Inc. (LCTX)
Market Closed
17 Jul, 15:25
TASE 
375. 60
ILA -0.2
-0.0532%
- Market Cap
- P/E Ratio
- Div Yield
4 Volume
-0.11 Eps
375.8 ILA
Previous Close Want to track LCTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.01 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LCTX Earnings Reports FAQ
What is the earnings per share (EPS) for LCTX?
The current EPS is -0.11.
What is the company's earnings growth rate?
Lineage Cell Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lineage Cell Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lineage Cell Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LCTX at this time, as Lineage Cell Therapeutics Inc has no recent EPS data to calculate it.
